Pioneering the profiling of glycosaminoglycans in early cancer detection
Learn how the partnership between a Swedish molecular diagnostics company and a multinational CMO aims to standardize the quantification of important cancer biomarkers
Learn how the partnership between a Swedish molecular diagnostics company and a multinational CMO aims to standardize the quantification of important cancer biomarkers
Join us on Tuesday, 20 April, to learn how technology-driven strategies can promote success and how automated science is a key driving factor
Join us Tuesday, July 6, to discover how to optimize your biomolecular interaction analyses for higher throughput and efficiency
In this guest editorial, Michaël van der Jagt, CEO of Parx Materials, discusses how the human immune system can inspire innovation
The clinical data for Avacta’s AffiDX SARS-CoV-2 antigen lateral flow test demonstrated 100% sensitivity
An asteroid strike on Earth could be prevented by new technology launching into space this year, involving a Queen’s University Belfast scientist
A research team led by physicians of the Karl Landsteiner University of Health Sciences in Krems uncovers a pivotal role for a regulator protein in tumor bone marrow angiogenesis
The next-generation organ-on-a-chip technology to be used to investigate the human gut microbiome for improving outcomes for patients with liver cirrhosis
Collaboration aims to provide new workflows, faster acquisition speeds and deeper resolution
Panbio COVID-19 Antigen Self-Test is approved for sale directly to consumers, enabling fast, convenient coronavirus testing
The Panbio self-test features a minimally invasive nasal swab and delivers results in as early as 15 minutes with no instrumentation, using proven Abbott lateral flow technology
Seward has launched the first sterile paddle blender bag that can also be autoclaved, reduces processing time, labor costs and plastic waste.
Offing end-to-end automation processes and technologies for electrification
The integrated platform from industry leaders will remove complexities in the patient journey to benefit all clinical trial stakeholders
The facility will be capable of manufacturing batches ranging from those for early-stage research to GMP for clinical and future commercial uses